Johnson & Johnson @ BIO-Europe Spring March 23–27, 2020
Creating a better world through health innovation and digital connections
Never before has it been more important to accelerate the impact of innovation. We remain at the leading edge of this health crisis, bringing our full resources and minds to combat it.
In line with our purpose, Johnson & Johnson Innovation will be engaging fully in BIO-Europe Spring, the largest life science partnering conference to be delivered digitally. We will continue making new connections virtually with innovators and entrepreneurs to accelerate lifesaving solutions for patients & consumers.
Johnson & Johnson Innovation’s role in collaborative partnerships
Johnson & Johnson Innovation in EMEA focuses on accelerating all stages of innovation across the region and forming collaborations between entrepreneurs and the Johnson & Johnson Family of Companies. Our purpose is to provide scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer health sectors.
Under our umbrella of businesses, we collaborate with innovators in EMEA through our Innovation Centre in London, UK, our incubator JLABS @ BE in Belgium, our strategic venture capital arm Johnson & Johnson Innovation - JJDC, Inc. and our Janssen Business Development teams. We create customized deals and novel collaborations that speed development of innovations to solve unmet needs in consumers and patients.Connect @ Bio-Europe Spring
We are proud to be the Double Helix sponsor of the BIO-Europe Spring conference, which is being delivered fully digitally for the first time ever. Hanneke Schuitemaker, Global Head of Viral Vaccine Discovery and Translational Medicine, Janssen Pharmaceuticals kicked off our engagement by participating on the opening Plenary Panel ‘Combating Coronavirus’ which will be webcast live. Other digital engagement (Note: login required) includes a Fireside Chat with William N. Hait, Global Head, External Innovation on 'Investing in innovation, new digital approaches for a new decade', and a Panel discussion with Guna Rajagopal, VP, Global Head, Computational Sciences, Discovery Sciences at Janssen on ‘Plugging into the data science and genomics ecosystem’.Finally on the closing Plenary Panel Sharon Chan, Head, JLABS, Shanghai, Johnson & Johnson Innovation joins other industry experts from China to discuss the ‘Road to recovery from Covid-19’.